TW358807B - Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole - Google Patents

Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole

Info

Publication number
TW358807B
TW358807B TW085112576A TW85112576A TW358807B TW 358807 B TW358807 B TW 358807B TW 085112576 A TW085112576 A TW 085112576A TW 85112576 A TW85112576 A TW 85112576A TW 358807 B TW358807 B TW 358807B
Authority
TW
Taiwan
Prior art keywords
benzisothiazole
piperazinyl
processes
intermediates
preparing
Prior art date
Application number
TW085112576A
Other languages
English (en)
Chinese (zh)
Inventor
Darrell Eugene Fox
John F Lambert
Jr Terry Gene Sinay
Stanley W Walinsky
Original Assignee
Pfizer Lnc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Lnc filed Critical Pfizer Lnc
Application granted granted Critical
Publication of TW358807B publication Critical patent/TW358807B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/26—Sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
TW085112576A 1995-11-07 1996-10-15 Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole TW358807B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US630195P 1995-11-07 1995-11-07

Publications (1)

Publication Number Publication Date
TW358807B true TW358807B (en) 1999-05-21

Family

ID=21720240

Family Applications (1)

Application Number Title Priority Date Filing Date
TW085112576A TW358807B (en) 1995-11-07 1996-10-15 Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole

Country Status (29)

Country Link
US (1) US6111105A (hu)
EP (1) EP0874834B1 (hu)
JP (1) JP3152938B2 (hu)
KR (1) KR100315939B1 (hu)
CN (1) CN1071324C (hu)
AR (2) AR004279A1 (hu)
AT (1) ATE198071T1 (hu)
AU (1) AU698443B2 (hu)
BR (1) BR9611366A (hu)
CA (1) CA2236940C (hu)
CO (1) CO4480028A1 (hu)
CZ (1) CZ290600B6 (hu)
DE (1) DE69611253T2 (hu)
DK (1) DK0874834T3 (hu)
ES (1) ES2152564T3 (hu)
GR (1) GR3035215T3 (hu)
HU (1) HU225921B1 (hu)
MX (1) MX9803599A (hu)
MY (1) MY116579A (hu)
NO (1) NO309811B1 (hu)
NZ (1) NZ318844A (hu)
PE (1) PE17298A1 (hu)
PL (1) PL185048B1 (hu)
PT (1) PT874834E (hu)
RU (1) RU2147302C1 (hu)
TR (1) TR199800814T2 (hu)
TW (1) TW358807B (hu)
WO (1) WO1997017336A1 (hu)
ZA (1) ZA969315B (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY27668A1 (es) 2002-02-20 2003-10-31 Pfizer Prod Inc Composición de ziprasidona y controles sintéticos
US20040048876A1 (en) * 2002-02-20 2004-03-11 Pfizer Inc. Ziprasidone composition and synthetic controls
EP1628973A2 (en) 2003-10-24 2006-03-01 Teva Pharmaceutical Industries Ltd. Processes for preparation of ziprasidone
US7777037B2 (en) * 2004-10-27 2010-08-17 Dr. Reddy's Laboratories Limited Ziprasidone process
CN105891392A (zh) * 2016-03-29 2016-08-24 北京万全德众医药生物技术有限公司 一种用液相色谱法分离测定盐酸鲁拉西酮中间体有关物质的方法
CN107064323A (zh) * 2016-12-05 2017-08-18 北京万全德众医药生物技术有限公司 一种用液相色谱法分离测定盐酸鲁拉西酮及其有关物质的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
JPH06220030A (ja) * 1993-01-22 1994-08-09 Sumitomo Pharmaceut Co Ltd ３−アミノ−１，２−ベンズイソチアゾール誘導体の製造法
JP3701044B2 (ja) * 1995-04-24 2005-09-28 住友精化株式会社 シアノベンゼンスルフェニルハライドおよびそれを用いる３−置換ベンゾイソチアゾールの製造方法
JP3996228B2 (ja) * 1996-10-11 2007-10-24 住友精化株式会社 ３−ピペラジニルベンズイソチアゾール類の製造法

Also Published As

Publication number Publication date
NO309811B1 (no) 2001-04-02
AR004279A1 (es) 1998-11-04
MY116579A (en) 2004-02-28
HU225921B1 (en) 2008-01-28
MX9803599A (es) 1998-09-30
HUP9903765A2 (hu) 2000-03-28
CN1071324C (zh) 2001-09-19
CA2236940A1 (en) 1997-05-15
PT874834E (pt) 2001-04-30
US6111105A (en) 2000-08-29
AU698443B2 (en) 1998-10-29
HUP9903765A3 (en) 2001-12-28
KR100315939B1 (ko) 2002-01-16
CZ137898A3 (cs) 1999-03-17
NZ318844A (en) 1999-04-29
CN1201457A (zh) 1998-12-09
KR19990067381A (ko) 1999-08-16
AR032373A2 (es) 2003-11-05
DE69611253D1 (de) 2001-01-18
GR3035215T3 (en) 2001-04-30
ATE198071T1 (de) 2000-12-15
DE69611253T2 (de) 2001-04-05
ES2152564T3 (es) 2001-02-01
JPH10512595A (ja) 1998-12-02
WO1997017336A1 (en) 1997-05-15
EP0874834B1 (en) 2000-12-13
BR9611366A (pt) 1999-02-23
ZA969315B (en) 1998-05-06
NO982051D0 (no) 1998-05-06
CA2236940C (en) 2001-08-21
PL185048B1 (pl) 2003-02-28
NO982051L (no) 1998-07-03
CZ290600B6 (cs) 2002-08-14
AU7092696A (en) 1997-05-29
PE17298A1 (es) 1998-04-16
CO4480028A1 (es) 1997-07-09
TR199800814T2 (xx) 1998-07-21
EP0874834A1 (en) 1998-11-04
PL326630A1 (en) 1998-10-12
JP3152938B2 (ja) 2001-04-03
RU2147302C1 (ru) 2000-04-10
DK0874834T3 (da) 2001-02-19

Similar Documents

Publication Publication Date Title
LU91554I2 (fr) "Brinzolamide et timolol optionnellement sous forme de sels pharmaceutiquement acceptables tel que la combination du produit brinzolamide/timolol maléate (AZARGA)"
CA2189007A1 (en) Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudormophs thereof
IL129871A (en) Process for preparing 4-phenyl-substituted octanoyl-oxazolidin-2-one intermediates that are useful for preparing pyran-2-ones useful for treating retroviral infections
EP0509019A4 (en) Treatment of human retroviral infections with 2',3'-dideoxyinosine
LU91178I9 (hu)
HK1026204A1 (en) Heterocyclic compounds process for their preparation and pharmaceutical compositions containing themand their use in the treatment of diabetes and related diseases.
HUP0102084A2 (hu) Kinolinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények
MXPA02008206A (es) Derivados de 2-oxo-1-pirrolidina, proceso para prepararlos y sus usos.
MY132671A (en) Substituted 6,6-hetero-bicyclic derivatives
FI102756B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 6H-bentsfuro[3a,3,3-ef][2]bentsatsepiinijohdannaisten valmistamiseksi
AU3631197A (en) N-benzylpiperidine and tetrahydropyridine derivatives
WO1992009281A3 (en) Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
TW362096B (en) Novel piperidine derivatives and the process for preparing the same
AU2838497A (en) Process for the preparation of substituted aryllactic acid- containing cyclodepsipeptides having 24 ring atoms
EP0776873A3 (en) Aqueous emulsion of alkylalkoxysilanes, process for its preparation and its use
TW358807B (en) Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole
HUP9903701A3 (en) Process for the preparation of 2-chlorothiazole derivatives, intermediates and preparation thereof
MY131277A (en) Process for chiral thiazolidine-2,4-dione hypoglycemics and intermediates
EP0619280A3 (en) Polymetallosilazane, process for its production, silicon nitride-based ceramic and process for its production.
NZ332545A (hu)
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
NO953988L (no) Ny fremgangsmåte for fremstilling av klonidinderivater
SE9800865D0 (sv) New Process
PH31612A (en) Amycolatopsis mediterranei strains useful to prepare A87689 compounds and process of preparing.
MX9703368A (es) Procedimiento para la preparacion de derivados de 1-halogeno-3-trialquilsilanil-benceno.

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees